tagraxofusp (Elzonris)

Indications

• blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults & children >= 2 years of age

Contraindications

• pregnancy, lactation

Adverse effects

• nausea, fatigue, fever, chills
• peripheral edema)
• weight gain
• laboratory abnormalities
  • lymphopenia, thrombocytopenia, anema
  • decreased serum albumin & serum calcium
  • hyperglycemia
  • increased serum transaminases (serum ALT & serum AST)

Boxed warning:

• capillary leak syndrome

More general terms

• antineoplastic agent (chemotherapeutic agent)